FDA accepts application for VP-102 for treating molluscum contagiosum. 7%(W/v) for the treatment of molluscum contagiosum. Am J Clin Dermatol. Pooled results of two randomized phase III trials evaluating VP-102, a drug-device combination product containing cantharidin 0.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |